catechin and Asialia

catechin has been researched along with Asialia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bisch, F; Derossi, S; Dickinson, D; Hahn, E; Hsu, S; Ma, YH; Ohno, S; Thomas, C; Yamamoto, T; Yates, N; Yu, H1
De Rossi, SS; Dickinson, DP; Hsu, S; Looney, S; Ogbureke, KU; Stuart, M; Thoppay, J1
Dickinson, D; Hsu, S1

Reviews

1 review(s) available for catechin and Asialia

ArticleYear
A new approach to managing oral manifestations of Sjogren's syndrome and skin manifestations of lupus.
    Journal of biochemistry and molecular biology, 2006, May-31, Volume: 39, Issue:3

    Topics: Anti-Inflammatory Agents; Antioxidants; Apoptosis; Camellia sinensis; Catechin; Female; Humans; Lupus Erythematosus, Systemic; Male; MAP Kinase Signaling System; Phytotherapy; Salivary Glands; Sjogren's Syndrome; Tea; Xerostomia

2006

Trials

1 trial(s) available for catechin and Asialia

ArticleYear
A phase II clinical trial of a natural formulation containing tea catechins for xerostomia.
    Oral surgery, oral medicine, oral pathology and oral radiology, 2014, Volume: 118, Issue:4

    Topics: Adult; Aged; Catechin; Double-Blind Method; Female; Humans; Male; Middle Aged; Plant Extracts; Quality of Life; Surveys and Questionnaires; Tea; Treatment Outcome; Xerostomia; Xylitol

2014

Other Studies

1 other study(ies) available for catechin and Asialia

ArticleYear
Epigallocatechin-3-gallate prevents autoimmune-associated down- regulation of p21 in salivary gland cells through a p53-independent pathway.
    Inflammation & allergy drug targets, 2014, Volume: 13, Issue:1

    Topics: Animals; Anticarcinogenic Agents; Catechin; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Diabetes Mellitus, Type 1; Disease Models, Animal; Down-Regulation; Epithelial Cells; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Proliferating Cell Nuclear Antigen; Retinoblastoma Protein; Salivary Glands; Sjogren's Syndrome; Tumor Suppressor Protein p53; Xerostomia

2014